• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺导管原位癌旁小叶的癌变及非典型导管增生

Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast.

作者信息

Goldstein N S, Lacerna M, Vicini F

机构信息

Department of Anatomic Pathology, William Beaumont Hospital, Royal Oak, Michigan 48073, USA.

出版信息

Am J Clin Pathol. 1998 Sep;110(3):357-67. doi: 10.1093/ajcp/110.3.357.

DOI:10.1093/ajcp/110.3.357
PMID:9728611
Abstract

Recurrent carcinoma develops in approximately 10% of patients with ductal carcinoma in situ (DCIS) of the breast treated with local excision and radiation therapy. Cancerization of lobules (COL) and atypical ductal hyperplasia (ADH)frequently occur at the edge of DCIS. We postulated that recurrent carcinoma is associated with ADH or COL near the DCIS excision margin, and the amount of DCIS left in the breast may be too large for eradication by radiation therapy. To identify histologic features associated with recurrence, we retrospectively studied specimens of 94 patients with DCIS treated by local excision and radiation. We analyzed the rim of tissue near the final margin for the amount of COL, ADH, and DCIS. During a median follow-up of 78 months, local recurrence developed in 9 patients. COL or ADH with DCIS near the final margin was associated with recurrence; the strongest relationship was with recurrences in the same site as the lumpectomy bed. DCIS with ADH was significantly associated with recurrence in the low-grade DCIS group; DCIS with COL was associated with recurrence in the high-grade group. Other features were not associated with outcome. We believe that ADH composed of cells identified as those of DCIS should be considered part of the DCIS lesion. DCIS may be inadequately excised if ADH and DCIS or COL and DCIS are near the margin.

摘要

在接受局部切除和放射治疗的乳腺导管原位癌(DCIS)患者中,约10%会发生复发性癌。小叶癌变(COL)和非典型导管增生(ADH)常发生在DCIS边缘。我们推测复发性癌与DCIS切除边缘附近的ADH或COL有关,且乳腺中残留的DCIS量可能太大,无法通过放射治疗根除。为了确定与复发相关的组织学特征,我们回顾性研究了94例接受局部切除和放射治疗的DCIS患者的标本。我们分析了最终边缘附近组织边缘的COL、ADH和DCIS量。在中位随访78个月期间,9例患者发生了局部复发。最终边缘附近伴有DCIS的COL或ADH与复发相关;最强的关联是与乳房肿瘤切除术床相同部位的复发有关。伴有ADH的DCIS在低级别DCIS组中与复发显著相关;伴有COL的DCIS在高级别组中与复发相关。其他特征与预后无关。我们认为,由被鉴定为DCIS细胞组成的ADH应被视为DCIS病变的一部分。如果ADH与DCIS或COL与DCIS靠近边缘,DCIS可能切除不充分。

相似文献

1
Cancerization of lobules and atypical ductal hyperplasia adjacent to ductal carcinoma in situ of the breast.乳腺导管原位癌旁小叶的癌变及非典型导管增生
Am J Clin Pathol. 1998 Sep;110(3):357-67. doi: 10.1093/ajcp/110.3.357.
2
Intraductal carcinoma of the breast: pathologic features associated with local recurrence in patients treated with breast-conserving therapy.乳腺导管内癌:保乳治疗患者局部复发相关的病理特征
Am J Surg Pathol. 2000 Aug;24(8):1058-67. doi: 10.1097/00000478-200008000-00003.
3
Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy.同时存在的增殖性高危病变对接受保乳治疗的导管原位癌患者同侧乳腺癌复发风险及对侧乳腺癌发生风险的影响。
Cancer. 2006 Jan 1;106(1):42-50. doi: 10.1002/cncr.21571.
4
Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.接受保乳治疗的乳腺钼靶检测原位导管癌患者局部复发的相关因素。
Cancer. 2000 Feb 1;88(3):596-607. doi: 10.1002/(sici)1097-0142(20000201)88:3<596::aid-cncr16>3.0.co;2-n.
5
Pathologic and technical considerations in the treatment of ductal carcinoma in situ of the breast with lumpectomy and radiation therapy.乳房导管原位癌保乳手术及放疗的病理与技术考量
Ann Oncol. 1999 Aug;10(8):883-90. doi: 10.1023/a:1008339113607.
6
Pathologic features of initial biopsy specimens associated with residual intraductal carcinoma on reexcision in patients with ductal carcinoma in situ of the breast referred for breast-conserving therapy.接受保乳治疗的乳腺导管原位癌患者初次活检标本的病理特征与再次切除时残留导管内癌的相关性。
Am J Surg Pathol. 1999 Nov;23(11):1340-8. doi: 10.1097/00000478-199911000-00004.
7
Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy.保乳治疗的导管原位癌患者中,切除体积、切缘状态和肿瘤大小与局部复发发展之间的关系。
J Surg Oncol. 2001 Apr;76(4):245-54. doi: 10.1002/jso.1041.
8
Ductal carcinoma in situ detected in the mammographic era: an analysis of clinical, pathologic, and treatment-related factors affecting outcome with breast-conserving therapy.乳腺钼靶筛查时代原位导管癌的诊治:影响保乳治疗效果的临床、病理及治疗相关因素分析
Int J Radiat Oncol Biol Phys. 1997 Oct 1;39(3):627-35. doi: 10.1016/s0360-3016(97)00314-3.
9
Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies.导管原位癌。保乳治疗的成功:两项单机构非随机前瞻性研究的共同经验。
Surg Oncol Clin N Am. 1997 Apr;6(2):385-92.
10
Possible Prognostic Role of HER2/Neu in Ductal Carcinoma In Situ and Atypical Ductal Proliferative Lesions of the Breast.HER2/Neu在乳腺导管原位癌及非典型导管增生性病变中的可能预后作用
Asian Pac J Cancer Prev. 2016;17(8):3733-6.

引用本文的文献

1
Influence of Cancerization of Lobules in Ductal Carcinoma In Situ of the Breast on the Pathological Outcomes in Mastectomy Specimens.乳腺导管原位癌中小叶癌变对乳房切除术标本病理结果的影响。
Cancers (Basel). 2025 May 12;17(10):1634. doi: 10.3390/cancers17101634.
2
Impact of Atypical Hyperplasia at Surgical Margins on breast cancer outcomes in patients treated with neoadjuvant chemotherapy.新辅助化疗患者手术切缘非典型增生对乳腺癌预后的影响。
Front Oncol. 2023 May 19;13:1202689. doi: 10.3389/fonc.2023.1202689. eCollection 2023.
3
Multicolor immunofluorescence reveals that p63- and/or K5-positive progenitor cells contribute to normal breast epithelium and usual ductal hyperplasia but not to low-grade intraepithelial neoplasia of the breast.
多色免疫荧光显示,p63和/或K5阳性祖细胞有助于正常乳腺上皮和普通导管增生,但对乳腺低级别上皮内瘤变无作用。
Virchows Arch. 2017 May;470(5):493-504. doi: 10.1007/s00428-017-2073-7. Epub 2017 Mar 16.
4
Impact of atypical hyperplasia at margins of breast-conserving surgery on the recurrence of breast cancer.保乳手术后切缘非典型性增生对乳腺癌复发的影响。
J Cancer Res Clin Oncol. 2014 Apr;140(4):599-605. doi: 10.1007/s00432-014-1597-3. Epub 2014 Feb 9.
5
Atypical Ductal Hyperplasia at the Margin of Lumpectomy Performed for Early Stage Breast Cancer: Is there Enough Evidence to Formulate Guidelines?早期乳腺癌保乳手术切缘的非典型导管增生:是否有足够证据制定指南?
Int J Surg Oncol. 2012;2012:297832. doi: 10.1155/2012/297832. Epub 2012 Dec 4.
6
Contemporary problems in the surgical management of breast cancer: the surgical/radiological interface.乳腺癌外科治疗中的当代问题:外科/放射学界面
Cancer Imaging. 2000 Oct 9;1(1):18-24. doi: 10.1102/1470-7330/00/010018+07.